Part 1: Tomorrow I’ll Know

Mandi Chambless • Dec 18, 2022

Written by Mandi Chambless for Cancer Wellness, Your Slice of Life

It’s five am and I’ve been awake for hours. The anxiety is suffocating. In my mind, I’ve been making plans for days now.


I don’t want them to have to do it for me.


As I stare up at my ceiling, every item in my room is clearly visible, although midnight shadows are cast upon every surface. I’ve been staring for long enough that my eyes have become accustomed to the darkness; each object as real and as tangible as the fear that’s steadily grown inside me for weeks now. 

I do my best to breathe slowly and deeply. I don’t want to wake Blane, my husband of 10 years, or arouse our three dogs that are quietly snoring on the floor at the foot of our bed. Tonight, this is my fear and my fear alone. 


Just a couple more days and I’ll know.


But what relief will come with the Knowing? Isn’t that when the hard part starts? 


The more I allow myself to think, the more panic begins to choke me. The more I try to calm my mind, the more it races. 


What will I tell them? How do I tell them? 


DO I tell them?


Just a couple more days. Then I’ll know. 


The ceiling fan whirs. It’s gentle breeze on my face; the only reminder at that moment that I am not alone. I’ve shared my fears with a couple of friends, although I can’t possibly share the enormity of this with anyone. It’s cruel, especially before I even know the truth myself. I can’t stand the thought of subjecting others to undue stress… I wonder if I’ll feel the same after I know. 


Then the pain comes, erupting through my abdomen as if it must make its presence known, refusing to be ignored. I shift onto my side, willing myself to relax but knowing that it’s impossible. It’s been two weeks, after all, and the pain is a frequent visitor. I quickly blink back the tears trying to escape the corners of my eyes, my pillow a patient and loving receptacle.


Something is wrong. 


What if…


No no no no no. Don’t go there. You can’t. 


But I have to. What other choice is there? 


I force my eyes closed, thinking the fervent prayer of a sinner facing their fate. Bargaining with God, making promises that may or may not be kept but are offered up as a sacrifice, regardless. As if God is oblivious to a human’s bluff in their greatest time of need…


Sleep finds me right around the time Blane’s alarm clock starts singing that agitating early morning tune. I’ll never understand early risers. I discreetly pull the long end of my pillow over my eyes slowly, making every effort to appear asleep. I don’t want to talk about it right now. 


Or ever.


He already knows. This time at least. He didn’t last time. Still doesn’t know about last time, at least not yet. It isn’t the first time and it most certainly won’t be the last. 

I feel him get out of bed and quietly close the double doors to our en suite bathroom. I’m wide awake now as he flips on our vanity lights, and the brightness illuminates the crack under the door. But it’s not the light that is robbing me of sleep. 


I lie still for what feels like seconds, but before I know it, an hour has passed and he’s silently walking out our garage door to get in his truck and head to work. I’m alone. But this is a feeling I know well.


Just a few more days and I’ll know.


Eventually I rise out of bed and go about my day, simultaneously ignoring the anxiety and pain taking turns ravaging my stomach. I feed the dogs; I have a meeting with my manager. I visit my customers in their offices and I send emails on my work laptop. I smile when I am supposed to. I force laughs at the appropriate moments. But I am a void. I go through the motions and I get through the day, but I am not present. I am inside myself, choking back terror and wondering how I will tell them. 

I wonder what it is that I will have to tell them.


I urge myself to make a run to the grocery store, but I’m not hungry. It’s more complicated than that — it has been painful to eat for days now. My distended belly expands even more with the slightest intake of food, and my waistband digs into my flesh, leaving an angry red indention. I push my cart through the aisles, not filling it with anything. My soul (and my abdomen) is busting at the seams already. I can’t take on anything else. Not even a box of Triscuits. My mind wanders as I look around at the other shoppers…


These people have no idea what I’m going through. No idea that in the back of my mind I am making a mental list of the songs I want played at my funeral. Wondering if I should fill a USB with pictures for the slide show so my husband doesn’t have to do it himself. Questioning the mundanity of everyday life but also already missing it before I’m even gone. 


Am I leaving right now? Is it slowly happening? Has my time come? 


My abdominal pain suddenly gets so severe that I struggle breathing. I lean on my empty shopping cart for support. This could quite possibly be due to anxiety, I tell myself. But it could also mean that the cancer has spread to my lungs.


Am I drowning from the inside without even knowing it? 


But maybe part of me does know it. 


I just want to go home. I abandon my empty cart and fish my keys out of my purse. I keep my head down as I walk out of the store and to my waiting car. Once safely inside, I sit there, in the parking lot, with my head leaned back on my headrest and eyes closed. The heat of the day engulfs me, but I don’t resent it. I let it enter every pore in my body because the discomfort is a distraction from the fire raging inside of me. Finally, I start my car and head home.

Early the following morning, history repeats itself and sleep yet again eludes me. But this day is different. Step one begins today.

Only a couple more days and I’ll know.


My stomach is in knots all morning, even as I walk in the doors of Texas Oncology. I am alone, as I prefer to be when I have a stressful appointment. COVID restrictions make it impossible to have support anyway, so why would I make Blane come with me? I give the receptionist my name and obediently take a seat in one of the turquoise chairs, waiting for my name to be called. I look around and catch a few glances from the elderly patients in the room. Their eyes dart away from mine and I know why. Although I’m 40 now, I still look “too young to have cancer.” I pretend to be busy on my phone until my name is called. 


I’m guided into the phlebotomy room, flanked on either side by two pleather chairs with large swinging armrests, and sit where directed.

“What’s your date of birth?” the nurse asks me as she pulls a label off a pad and wraps it around a specimen container. 


I politely answer as she wipes the crook of my right arm with an alcohol pad, the coolness shocking my mind out of its haze for a moment. She feels for a vein, and I take a deep breath in as I turn my head to the left to ensure the needle is out of my range of vision. 

Normally it doesn’t bother me. Today, it feels as if it will kill me. 


She fills four vials with my blood, then pulls out the needle and has me press a cotton swab to my arm. She wraps purple gauze tightly around my arm and sends me on my way. I say a prayer over those vials as I stand up and leave the room, willing them to be normal and healthy. And now I wait.

A 30-second appointment holds the answers to what is remaining of my life. 


I head home and do my best to get on with my day. A call with my manager, emails to customers. Blane comes home, makes dinner and asks me how I’m feeling. I answer truthfully, but succinctly. He knows I don’t want to talk about it. He wants to help me but doesn’t know how. I don’t know how either. How do I tell him what I need when I can’t even put it into words? How can he help me when he’s every bit affected by this as I am? I don’t even want physical touch right now. Not even a hug. It’s restricting and makes me feel guilty. It also makes this more real. 


Music plays in the background. Ben Folds Five comes on. “She’s a brick and I’m drowning slowly…” My gut wrenches. How on earth can we possibly be expected to know what to do?


Only two more days and I’ll know. 


The Day Before is here and I have to admit that it’s better than Yesterday. I don’t know why it’s better but getting Step One out of the way has certainly eased my mind a little. It gave me a goal to achieve. A box to check; as if I had done something about “it.” My nerves are still working me over but I do feel slightly more content, and my stomach pain has slightly subsided. I can get through this day OK, I think. 

Tomorrow I’ll know.


A feeling comes over me and I take a break from work and grab my personal laptop. A sudden growing and insistent sense of urgency to write engulfs me. The need to put my story in writing before it’s too late. The words of one of my best friends and survivor confidants have rung in the recesses of my mind for a couple years now: “I want to finish my book soon so that my husband doesn’t have to finish it for me someday.” Her words seem to be getting louder in my head with every day that passes in which I continue to feel discomfort in my abdomen. 


Twelve and a half years ago, an oncologist at MD Anderson Cancer Center in Houston, Texas, said “I’m sorry,” after informing me that I had stage IIIC ovarian cancer and had a whopping 20 percent chance to live five more years. I was only 28 years old. In the midst of my terror, I wrote. In the midst of my pain, I had to tell my story. This, what you are reading right now, is as true as it gets for an ovarian cancer survivor. The disease is dubbed the “silent killer,” its menacing grip initially so subtle that most women aren’t aware of its presence until it is too late. A venerable wolf in sheep’s clothing, mimicking minor gastrointestinal issues that are all too easy to shrug off, leading to plummeting survival rates and skyrocketing numbers of lives lost. 


It never ends, even though we look healthy. When the pain comes, we don’t have the luxury of shrugging it off as a stomachache. It never ends, worrying about our future, or lack thereof. Me telling them it’s back. Flashes of my family together at Christmas without me. My husband alone in our home. Me, not existing anymore. 

As I am typing these words, I am encased into my own version of hell. It simply never ends.


Guilt.

Pain.

Shame.

Fear.



Tomorrow I’ll know.

20 Dec, 2023
Scottsdale girl’s lemonade stand raises nearly $10,000 for ovarian cancer research Chloe Cundiff made $1,000 on a cup of lemonade once. Then, she donated it all to a non-profit for ovarian cancer research. The 9-year-old Scottsdale girl raised almost $10,000 in lemonade stand sales from the first day of summer to Oct. 1.  She was the grand prize winner of the “Take a Lemonade Stand” program, which donated 100 lemonade stands to Arizona kids this summer to teach them entrepreneurial skills and instill a spirit of community giving, according to a press release. Cundiff has donated 100 percent of her profits to the Scottsdale-based Colleen’s Dream Foundation, which was started by her mom and dad to raise money for ovarian cancer research.
By Mandi Chambless 06 Dec, 2023
Written by Mandi following her Mount Everest Base Camp Trek
By Mandi Chambless 30 May, 2023
Written by Mandi following her Mount Everest Base Camp Trek
19 Aug, 2020
Greg Conry, a dedicated supporter of ovarian cancer research, biked 3,200 miles across America to raise money for Colleen’s Dream! Greg grew up in Westphalia, Iowa and was the placekicker for the Harlan Community Cyclones. Greg "The Leg'' went on to be a very successful collegiate kicker at Peru State College. He also kicked for the National Arena League Sioux City Bandits for several seasons. He and his wife, Carly, teach and reside in Hinton, IA. Greg and his family are also avid bikers and Greg completed his 18th RAGBRAI in 2023. Greg began supporting Colleen's Dream Foundation through Kicking for a Dream in High School and College. Then in June 2020, Greg launched Greg's Ride Across America! He rode nearly 3,000 miles on his bike from Oceanside California, to Dewey Beach, Delaware! Greg raised over $19,000 for Colleen's Dream Foundation during the course of his 42 day journey! Check out these stats: 2,911.7 miles 132,480 feet of climb 190 hours, 45 minutes on the bike 15.3 mph average 13 states ridden through 8,200+ miles driven $19,000 and counting raised 81 miles averaged per day 13 days of near century or century rides (100 miles) Greg's dad, Tom Conry, created a great video capturing Greg's Ride Across America! Colleen's Dream Fundraiser for Ovarian Cancer Read all the details about his Ride for the Dream on the Facebook page.
06 May, 2019
The recent partnership between Pacific Retail Capital Partners (PRCP) and Butterfly Effect (BE) will fly to new heights on May 8 in support of women around the globe. For World Ovarian Cancer Day, photos taken with the interactive “Social Butterfly” murals located at Pacific Retail shopping centers across the nation will benefit ovarian cancer research on behalf of nonprofit, Colleen’s Dream Foundation (CDF). CDF is a 501(c)(3) organization dedicated to educating individuals and raising awareness for ovarian cancer, a particularly evasive disease nicknamed the Silent Killer. For 24 hours, individuals can visit the painted butterflies as part of a movement created by Tasha Wahl and the Butterfly Effect. These murals encourage passersby to snap a photo with the butterfly and share it on social media. A donation will be made to ovarian cancer research for every photo shared with the tags #ColleensDreamFoundation , #PacificRetail and #ButterflyEffec t . The unique series of butterflies can be found at eight participating Pacific Retail centers: Broadway Commons in Hicksville, N.Y.; Colonie Center in Albany, N.Y.; Eastridge Center in San Jose, Calif.; Military Circle in Norfolk, Va.; The Shops at Montebello in Montebello, Calif.; Northpark in Ridgeland, Miss.; the Shops at South Town in Salt Lake City, Utah; and Yorktown Center in Lombard, Ill. “We are in the unique position to make a significant impact in the name of women’s health,” said Najla Kayyem, Senior Vice President of Marketing for PRCP. “We already have learned from Colleen’s Dream Foundation about ovarian cancer. Particularly, the alarming fact that early detection methods do not exist. We’re proud to stand in solidarity with women around the world battling the disease.” CDF raises awareness for ovarian cancer and supports research that will lead to improved treatment and reliable early-detection. No such screening currently exists, which is a leading factor as to why ovarian cancer is the deadliest gynecological cancer. Of all women diagnosed, 25 percent die in the first year, largely because diagnosis occurs in the later stages of the cancer. “Many people are in the dark about the dangers of ovarian cancer,” said Nicole Cundiff, CEO of CDF. “One in 78 women will develop the disease, the signs and symptoms are so vague, and your yearly wellness visit doesn’t test for it. That’s why shining a national spotlight on ovarian cancer through this partnership means everything to us.” Since its inception in 2012, CDF awarded 48 research grants to 27 institutions totaling more than $1.2 million. Past recipients of Colleen’s Dream funding include, the University of Arizona Cancer Center, the University of Texas MD Anderson Cancer Center, Johns Hopkins University, Duke Cancer Institute and the University of Nebraska Medical Center, among others. To learn more about ovarian cancer, CDF or how you can help, visit www.colleensdream.org . For more information about Butterfly Effect, visit https://butterflyeffectbethechange.com/ . About Colleen’s Dream Foundation Colleen’s Dream is a qualified 501(c)(3) nonprofit organization founded in 2012 by Nicole Cundiff and her husband, Billy, a 12-year veteran kicker in the NFL. Colleen’s Dream is dedicated to funding investigational scientific research with the primary goal of developing and establishing an accurate and accessible early detection test for ovarian cancer. For more information about Colleen’s Dream Foundation, or to donate, call (480) 269-2266 or visit www.colleensdream.org . About Pacific Retail Capital Partners Pacific Retail Capital Partners (PRCP) is one of the nation’s premier retail operating groups of large open-air and enclosed shopping centers, with more than $1.5 billion in retail assets presently under management in the United States. Based in Southern California, PRCP provides end-to-end sourcing, assessment, underwriting, valuing, developing, and asset management of retail real estate with a proven track record of repositioning properties. PRCP strategically manages over 10 million square feet of retail destinations. The executive team has over 150 years of collective real estate expertise in leasing, marketing, operations, design, development, investment and finance. With a keen focus on enhancing the value and quality of its growing portfolio, PRCP is dedicated to creating a unique, strategic vision for each property and exceeding the highest expectations of retail investors, retailers and consumers. To learn more, visit pacificretail.com or follow social media at: Facebook: facebook.com/pacificretailcapitalpartners Instagram: @pacificreta
26 Apr, 2018
Scottsdale-based nonprofit grants $450,000 to Phoenix research institute, TGen SCOTTSDALE, ARIZ. — April 3, 2018 — Colleen’s Dream Foundation , a Scottsdale-based nonprofit dedicated to supporting ovarian cancer research, recently awarded Translational Genomics Research Institute (TGen) $450,000 to fund a clinical trial for a newly developed ovarian cancer drug treatment. Colleen’s Dream celebrated its fifth annual fundraising event, the Evening of Dreams Gala in late February. This year’s gala was record-breaking for the foundation, with more than 650 attendees and $200,000 raised from the live auction and paddle raise portion of the evening alone. Combined with prior Colleen’s Dream donations to TGen, this support will fully enable the clinical trial. “The research being done at TGen is some of the most exciting we’ve ever seen,” said Nicole Cundiff, CEO of Colleen’s Dream Foundation. “Whether the drug they developed leads to another amazing discovery, or it becomes a first line ovarian cancer treatment, we truly believe what they’re doing will move the needle and we couldn’t be more proud to support an institute located here in Arizona.” TGen, based in Phoenix, alongside an international team of collaborators, discovered a mutation in a gene known as SMARCA4, which drives a specific type of extremely aggressive ovarian cancer known as Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT). SMARCA4 is known as an “epigenetic” gene that broadly controls how other genes are regulated in the genome. When SMARCA4 is mutated, it is broken and cancer can develop through sweeping epigenetic imbalances. From this discovery, TGen evaluated experimental drugs that can restore epigenetic balance. One such drug, seclidemstat, has shown promising preclinical results in ovarian cancers and also is currently being clinically evaluated in other cancers driven by epigenetic imbalances. Seclidemstat was developed by Salarius Pharmaceuticals of Houston, which was established with the help of Dr. Sunil Sharma, TGen Deputy Director of Clinical Sciences and Director of TGen’s Applied Cancer Research and Drug Discovery Program. “Our partnership with Colleen's Dream has been critical for driving our translational research toward clinical,” said Dr. Will Hendricks, an Assistant Professor in TGen’s Integrated Cancer Genomics Division. “We look forward to building on preclinical studies of epigenetic anti-cancer drugs that have identified seclidemstat as a promising lead for ovarian cancer treatment.” Colleen’s Dream Foundation raises funding to support research that will lead to improved treatment and reliable early-detection of ovarian cancer. No such test currently exists, which is a leading factor as to why ovarian cancer is the deadliest gynecological cancer. Of all women diagnosed, 25 percent die in the first year, largely because diagnosis occurs in the later stages of the cancer. Since its inception, Colleen’s Dream awarded 48 research grants to 27 institutions totaling more than $1.2 million. Past recipients of Colleen’s Dream funding include, the University of Arizona Cancer Center, the University of Texas MD Anderson Cancer Center, Johns Hopkins University, Duke Cancer Institute and the University of Nebraska Medical Center, among others. Colleen’s Dream first awarded TGen a $30,000 grant in February 2017, which supported the institute’s understanding of the epigenetic events of the SMARCA4 mutations in SCCOHT and led to the most recent clinical trial. To learn more about ovarian cancer, Colleen’s Dream Foundation or how you can help, visit www.colleensdream.org . To learn more about this clinical trial, including when it will start and who might be eligible, please contact Callie Hammersland, TGen Clinical Research Manager, at 602-343-8653 or chammersland@tgen.org . # # # About Colleen’s Dream Foundation Colleen’s Dream is a qualified 501(c)(3) nonprofit organization founded in 2012 by Nicole Cundiff and her husband, Billy, a 12-year veteran kicker in the NFL. Colleen’s Dream is dedicated to funding investigational scientific research with the primary goal of developing and establishing an accurate and accessible early detection test for ovarian cancer. For more information about Colleen’s Dream Foundation, or to donate call (480) 269-2266 or visit www.colleensdream.org . Media Contact: Keller Perry The James Agency Keller@TheJamesAgency.com (480) 248-6710 About TGen Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, diabetes, and infectious diseases, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. TGen is affiliated with City of Hope, a world-renowned independent research and cancer and diabetes treatment center: www.cityofhope.org . This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. For more information, visit: www.tgen.org . Follow TGen on Facebook , LinkedIn and Twitter @TGen . TGen Media Contact: Steve Yozwiak TGen Senior Science Writer 602-343-8704 syozwiak@tgen.org
29 Mar, 2018
Colleen’s Dream Foundation celebrated its 2018 Golf Tournament and Evening of Dreams Gala on Feb. 23 and Feb. 24. The golf tournament was played at the Biltmore Golf Club, Adobe Course on Friday, followed by dinner and awards. In its fifth year, the Saturday evening gala took as its theme Dream in Color, and was held at the JW Marriott Scottsdale Camelback Inn Resort and Spa. The event is celebrated each year on the anniversary of Colleen Drury’s passing. Colleen is the namesake and was the inspiration for the ovarian cancer nonprofit. The foundation was founded by her daughter Nicole Cundiff and Nicole’s husband, Billy, in 2012. Ten-year-old Chloe Cundiff was awarded the Dreamer of the Year Award for raising nearly $10,000 for Colleen’s Dream during her summer break by selling lemonade. The evening’s program concluded with 29-year-old Brittany Crosby, an ovarian cancer fighter who shared her story of diagnosis and her current battle with the disease. The 660 guests at the gala enjoyed live music provided by The JJ’s followed by an after-party, which moved to a different section of the ballroom where there was an additional dance floor and a DJ set by DJ Soloman. A Champagne fairy with Showstoppers Interactive Entertainment poured drinks. The golf tournament and gala raised funds for ovarian cancer research, with the majority going to Phoenix research institute TGen for a clinical trial. The two events, plus the VIP kickoff reception on Feb. 22, enabled Colleen’s Dream to award $350,000 to TGen. PHOTOS COURTESY COLLEEN’S DREAM FOUNDATION
23 Mar, 2018
The fifth annual Evening of Dreams Gala benefiting Colleen’s Dream Foundation took place in February at the JW Marriott Desert Ridge and raised approximately $270,000, with the majority of the funds going to TGen for an ovarian cancer treatment clinical trial. The evening featured a silent auction, hosted cocktail hour, dinner and live auction. The program included a review of the foundation’s year by co-founder and chair of the Board of Directors Billy Cundiff. Then, the 2017 Dreamer of the Year, was awarded to Chloe Cundiff.Chloe is the granddaughter of Colleen, the foundation’s namesake, and the daughter of co-founders Billy and Nicole Cundiff. The 9-year-old raised nearly $10,000 for the foundation by selling lemonade during her summer break .Emmy Award-winning writer and television host Teresa Strasser served as the evening’s emcee .colleensdream.org
01 Nov, 2017
Colleen’s Dream Foundation, a non-profit dedicated to supporting research for early detection and improved treatment for ovarian cancer, awarded $20,000 in research grants to the University of Chicago Medicine. The two grants of $10,000 each support a pair of young researchers studying the disease that affects approximately 20,000 newly diagnosed women in the U.S. each year. Ovarian cancer is the deadliest of gynecological cancers as it often goes undiagnosed until it is in an advanced stage and has metastasized (or is metastasizing) beyond a woman’s ovaries. The Arizona-based non-profit awarded the two grants to UChicago Medicine post-doctoral researchers Peter Hart, PhD, and Abir Mukherjee, PhD. The two work in the laboratory of Ernst Lengyel, MD, PhD and Iris Romero, MD. Lengyel is the Arthur L. and Lee G. Herbst Professor of Obstetrics/Gynecology at the University of Chicago the chairman of UChicago Medicine’s Department of Obstetrics/Gynecology. Romero, an associate professor of Obstetrics/Gynecology, specializes in treating women at risk of hereditary breast and ovarian cancer. Together, Lengyel and Romero run a lab dedicated to translational ovarian cancer research. “Part of our mission is to support young investigators, such as Drs. Hart and Mukherjee, to encourage their curiosity and to help push the envelope of cutting-edge research,” said Nicole Cundiff, co-founder and CEO of Colleen’s Dream Foundation. “We’re eager to see what these gentlemen will discover in their pursuit to learn more about how ovarian cancer spreads.” Hart, 31, will use the funding to examine whether a common diabetes treatment called metformin can prevent ovarian cancer cells from spreading and growing into secondary tumors. By learning how this treatment affects ovarian cancer, Hart hopes his work could ultimately lead to novel therapeutic strategies that keep the disease from spreading. “While there have been major strides in research of breast and other highly prevalent cancers, there has been slower progress in improving outcomes for ovarian cancer,” Hart said. “Understanding how an economical and safe medication like metformin affects ovarian cancer metastasis may help us improve survival and quality of life for women with this disease.” Mukherjee, 36, studies the interaction between ovarian cancer cells and fat tissue in the abdominal cavity to learn more about how these cells influence each other and affect cancer’s growth and metastasis. His studies have identified potential targets and through this grant he hopes to explore whether targeting a specific enzyme could lead to better treatments. “Ovarian cancer patients often have a high metastatic burden and have cancer that often recurs after undergoing chemotherapy,” Mukherjee said. “The need of the hour is to identify novel therapeutic targets for this fight.” About the University of Chicago Medicine & Biological Sciences The University of Chicago Medicine, with a history dating back to 1927, is one of the nation’s leading academic medical institutions. It comprises the University of Chicago Medical Center, Pritzker School of Medicine and the Biological Sciences Division. Its main Hyde Park campus is home to the Center for Care and Discovery, Bernard Mitchell Hospital, Comer Children’s Hospital and the Duchossois Center for Advanced Medicine. It also has ambulatory facilities in Orland Park and the South Loop as well as affiliations and partnerships that create a regional network of care. UChicago Medicine offers a full range of specialty-care services for adults and children through more than 40 institutes and centers including an NCI-designated Comprehensive Cancer Center. It has 811 licensed beds, nearly 850 attending physicians, about 2,500 nurses and over 1,100 residents and fellows. Harvey-based Ingalls Health joined UChicago Medicine’s network in 2016. Visit our research blog at sciencelife.uchospitals.edu and our newsroom at uchospitals.edu/news. Twitter @UChicagoMed Facebook.com/UChicagoMed Facebook.com/UChicagoMedComer About Colleen’s Dream Foundation Colleen’s Dream Foundation is a qualified 501(c)(3) nonprofit organization dedicated to funding investigational scientific research with the primary goal of developing an accurate early detection test for ovarian cancer. Currently, no such test exists, making ovarian cancer the deadliest of all gynecological cancers. Colleen’s Dream was founded in 2012 by Nicole Cundiff and her husband, Billy, a 12-year veteran kicker in the NFL. In the short time Colleen’s Dream has been operational, the foundation has granted more than $700,000 to ovarian cancer research and quickly became the largest, privately funded, ovarian cancer specific nonprofit in the state of Arizona.
09 Jan, 2014
High School Kicking Specialists Help Kicking for the Dream Raise Over $40,000 to Fight Ovarian Cancer in Its 2013 Fundraising Campaign
Share by: